Fijian health authorities declared a national health emergency following a sharp surge in HIV infections, with diagnoses jumping 27% in a single year to 2,016 new cases in 2025, according to UNAids data. In the island nation of approximately 930,000 residents, an estimated 9,100 people are now living with the virus, translating to roughly one in 60 adults.
Surging Infections Driven by Youth and Drug Use
The epidemic is heavily concentrated among younger populations, with new diagnoses peaking in individuals aged 15 to 34. Healthcare teams conducting mobile testing have found high positivity rates among teenagers; during one recent Friday night screening outside a McDonald’s in downtown Suva by Medical Services Pacific, one in six of the 97 people tested positive for the virus.
According to health officials, more than 42% of new cases in 2025 stem from sharing contaminated needles and drug injection equipment. The crisis is closely tied to methamphetamine distribution, as Fiji functions as a regional transit hub for drugs moving toward Australian and New Zealand markets, while domestic consumption grew significantly following pandemic-era border closures.
Dr. Jason Mitchell, head of Fiji’s HIV epidemic response, stated that bringing the virus under control could take between five and 10 years, during which time case numbers are expected to continue climbing. Public health advocates note that primary school-age children are among those injecting drugs and sharing needles, a vulnerability first highlighted by advocates in 2019.
Emergency Response and the Needle Distribution Debate
To curb the outbreak, the Fijian government has scaled up a pandemic declaration initially issued in February 2025, committing an estimated extra $23m FJD (US$10.2m) annually to support vulnerable populations, including mothers and babies. Dr. Kesaia Tuidraki, country director of Medical Services Pacific, emphasized the urgency of expanding harm-reduction measures, noting that boxes of unused needles and syringes remain stored in a Suva warehouse while transmission rates climb.
Under existing laws, distributing syringes has technically constituted aiding and abetting drug use, creating a legal hurdle that prevented public health workers from distributing sterile equipment. However, Dr. Jason Mitchell indicated that an amendment to the HIV Act is expected to pass within two weeks, granting public health workers the authority to distribute needles.
International support has accompanied the domestic response. UNAids regional director Eamonn Murphy described the needle and syringe program as critical to halting the immediate crisis. Australia announced A$48m in November to combat HIV and AIDS across the Pacific, while New Zealand committed NZ$4.2m to Fiji in July.
Stigma and Barriers to Testing
Despite the escalation of resources, public health campaigns face hurdles from social stigma and low testing rates. UNAids estimates that only 39% of individuals living with HIV in Fiji are aware of their status, with many others remaining in denial or refusing screening altogether.
Advocates report that minority groups, including the queer community and women, face intense online cyberbullying and blame as the crisis receives heightened public attention. Mark Shaheel Lal, an advocate who lives with HIV, noted that the situation is frequently treated as a scandal, leaving vulnerable populations fearful. Regional health agencies are also monitoring rising infection rates in neighboring nations including the Solomon Islands and Papua New Guinea.
Related reading